As a result, numerous studies have contributed to elucidate the involvement of CX3CL1 and its specific receptor CCX3CR1 in the progression of different neuroinflammatory and neurodegenerative processes, with Alzheimer’s and Parkinson’s diseases being the most studied ones. This evidence concerns the gene CX3CL1 and Parkinson disease.